Showing papers in "Revue Neurologique in 2020"

TL;DR: A systematic review of pharmacotherapy, neurostimulation, surgery, psychotherapies and other types of therapy for peripheral or central neuropathic pain, based on studies published in peer-reviewed journals before January 2018, concludes that psychotherapy (cognitive behavioral therapy and mindfulness) is recommended as a second-line therapy, as an add-on to other therapies.

TL;DR: Future epidemiological studies and case records should elucidate the real incidence of neurological complications, their pathogenic mechanisms and their therapeutic options in patients affected by COVID-19.

TL;DR: The unfavorable emergency context related to COVID-19 may specially affect the potential for intensive care admission (ICU) for people with NMD and, in order to preserve the fairest medical decision, a multidisciplinary working group has listed the neuromuscular diseases with a good prognosis, usually eligible for resuscitation admission in ICU and, for other NM conditions, the positive criteria suggesting aGood prognosis.

TL;DR: Melatonin may have a prophylactic and therapeutic effect on neurological diseases and strong collaboration between neurologists and health service policy makers is needed to encourage use of melatonin in the patients suffering from neurological diseases.

TL;DR: Diet and sex are two factors that have been reported to alter ALS risk, onset and progression in humans and in animal models, providing potential modifiers of disease.

TL;DR: An overview of the earlier and latest advances in the management of Parkinson's disease, from L-DOPA to adult astroglia reprogramming into dopaminergic neurons in vivo is presented.

TL;DR: Serum levels of 25(OH)D concentration is lower in patients with migraine than healthy individuals, and investigation of the effect of vitamin D supplementation in patients suffering from migraine is warranted.

TL;DR: Longitudinal population-based studies provide useful insights for a better understanding of the specificities of neurological diseases in older adults by assessment of a wide range of risk factors.

TL;DR: The results clearly indicate that CGRP/rec mAbs are significantly superior to placebo and have been comprehensively reviewed by Dodick, and their major advantage seems not to be chiefly their superior efficacy but their unprecedented efficacy over adverse event ratio.

TL;DR: An overview of current knowledge of SE etiologies and a pragmatic approach for carrying out an etiological assessment based on the following steps are presented.

TL;DR: Current evidence on common clinical features and bedside signs in FMD, such as tremor, dystonia, myoclonus and parkinsonism are summarized and highlighted.

TL;DR: The aim of this work is to describe the history of dementia and Alzheimer's disease concepts, from early descriptions in antiquity, through studies and authors from different historical periods throughout the centuries, to the latest updates of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).

TL;DR: Recent evidence indicating that fingolimod may target both the inflammatory and neurodegenerative components of the disease process in MS is discussed.

TL;DR: CHADS2 and CHA2DS2-VASc scores were both associated with stroke outcomes regardless of atrial fibrillation and these scores can be useful tools for the prognosis stratification of a patient with an ischemic stroke.

TL;DR: In LCC, the clinical spectrum is largely heterogeneous and the course of the disease appears highly variable in contrast to other hereditary cerebral small vessel diseases.

TL;DR: This review focuses on the hope raised by the development of novel, implantable biomaterials that should favor the reconstruction of the damaged nervous tissue, and ultimately allow for functional recovery of sensorimotor functions.

TL;DR: The literature is reviewed to present current issues and perspectives for DBS programming in PD and to propose a few algorithms proposed by experts for the initial programming and management of some adverse effects.

TL;DR: Diagnosis in this population may be difficult, as the clinical presentation is often not very suggestive (stupor, confusion, even coma), and requires an unrestricted use of EEG with an EEG diagnosis based on the EEG with now accepted criteria (so-called Salzburg EEG criteria).

TL;DR: Characteristics of pediatric onset multiple sclerosis are reviewed in this review characteristics of POMS.

TL;DR: The infectious risk with immunosuppressive therapies is described and minimal screening recommendations are proposed to evaluate the risk and adapt the prevention and strategy of immunization to each case at multiple sclerosis diagnosis and at specific follow-up visits to avoid difficulties using live-attenuated vaccines or risk reduced immune responses.

TL;DR: The blood glucose variability is an independent predictor of death in patients with severe acute stroke and great range of glycemic excursion indicates poor disease outcome, while the mean blood glucose level does not have significant correlation with the outcomes of patients.

TL;DR: In this article, the authors proposed a genetic cause of frontotemporal lobar degeneration (FTLD) in a more rapid and efficient way using next-generation sequencing.

TL;DR: In this article, the authors conduct a literature search to collect available evidence on the relationship between disease-modifying therapies in multiple sclerosis and SARS-CoV-2 infection, together with the experience of the authors in the management of patients with multiple sclerosis during the pandemic.

TL;DR: Mitochondrial trifunctional protein deficiency is described as a newly hereditary etiology of sensory neuronopathy in adults, specifically in patients with c.1528G>C mutation, and should be screened for by performing plasma acylcarnitines in Patients with chronic sensory neuronsopathy and additional suggestive features such as exercise intolerance or retinopathy.